Stanford-StartX Fund (DEFUNCT)

Stanford-StartX Fund (DEFUNCT)

Invests minority equity in Stanford-affiliated startup follow-on rounds alongside independent professional investors.

The Stanford-StartX Fund was a co-investment vehicle established in 2013 as a partnership between Stanford University, Stanford Health Care, and the StartX accelerator. It operated as an uncapped minority co-investor in StartX portfolio companies, following the lead of independent professional investors rather than leading rounds. To qualify, a company was required to have independently raised a minimum of $500,000 from professional investors; the Fund then invested on matching terms alongside that outside capital. The Fund focused on for-profit startups with at least one Stanford-affiliated team member, spanning sectors including biotech, hardware, AI, and medtech.

The Stanford-StartX Fund made no direct grants and charged no fees; its instrument was equity co-investment. It was funded by Stanford University and Stanford Hospital and operated for approximately six years. In January 2019, Stanford announced it would discontinue support for the Fund, citing StartX's achievement of financial self-sustainability. The Fund ceased making new investments in June 2019. No successor vehicle or replacement funding program was announced at the time of wind-down.

As of the date of this record, the Stanford-StartX Fund is defunct and is no longer accepting applications or making investments. Organizations seeking Stanford-affiliated startup support should look to the continuing StartX accelerator community, which remains active as an independent non-profit and provides equity-free, non-cash resources to Stanford-affiliated founders.